BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 27465596)

  • 21. Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.
    Van den Wyngaert T; Helsen N; Carp L; Hakim S; Martens MJ; Hutsebaut I; Debruyne PR; Maes ALM; van Dinther J; Van Laer CG; Hoekstra OS; De Bree R; Meersschout SAE; Lenssen O; Vermorken JB; Van den Weyngaert D; Stroobants S;
    J Clin Oncol; 2017 Oct; 35(30):3458-3464. PubMed ID: 28854069
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorodeoxyglucose positron emission tomography for the preoperative staging of oral cavity cancers: only one piece of the puzzle.
    Waldron JN
    J Clin Oncol; 2006 Sep; 24(27):4367-8. PubMed ID: 16983103
    [No Abstract]   [Full Text] [Related]  

  • 23. Prognostic Role of Circulating Tumor Cells during Induction Chemotherapy Followed by Curative Surgery Combined with Postoperative Radiotherapy in Patients with Locally Advanced Oral and Oropharyngeal Squamous Cell Cancer.
    Inhestern J; Oertel K; Stemmann V; Schmalenberg H; Dietz A; Rotter N; Veit J; Görner M; Sudhoff H; Junghanß C; Wittekindt C; Pachmann K; Guntinas-Lichius O
    PLoS One; 2015; 10(7):e0132901. PubMed ID: 26186556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating tumour cells in metastatic head and neck cancers.
    Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
    Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of recurrent oral squamous cell carcinoma by [18F]-2-fluorodeoxyglucose-positron emission tomography: implications for prognosis and patient management.
    Kunkel M; Förster GJ; Reichert TE; Jeong JH; Benz P; Bartenstein P; Wagner W; Whiteside TL
    Cancer; 2003 Nov; 98(10):2257-65. PubMed ID: 14601097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solitary peritoneal lymph node metastasis of head and neck cancer diagnosed with FDG-PET/CT imaging.
    Kim YW; Lee BJ; Lee JC; Jeon TY; Kim HJ
    Ear Nose Throat J; 2014 Dec; 93(12):E28-30. PubMed ID: 25531851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Contralateral lymph neck node metastasis of squamous cell carcinoma of the oral cavity: a retrospective analytic study in 315 patients.
    González-García R; Naval-Gías L; Rodríguez-Campo FJ; Sastre-Pérez J; Muñoz-Guerra MF; Gil-Díez Usandizaga JL
    J Oral Maxillofac Surg; 2008 Jul; 66(7):1390-8. PubMed ID: 18571022
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 18F fluorodeoxyglucose PET/CT in head and neck squamous cell carcinoma with negative neck palpation findings: a prospective study.
    Roh JL; Park JP; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
    Radiology; 2014 Apr; 271(1):153-61. PubMed ID: 24475791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous cell carcinoma of the oral cavity or oropharynx: A comparison with (18)F-FDG PET.
    Krabbe CA; van der Werff-Regelink G; Pruim J; van der Wal JE; Roodenburg JL
    Head Neck; 2010 Mar; 32(3):368-74. PubMed ID: 19626632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-PET in the clinically negative neck in oral squamous cell carcinoma.
    Wensing BM; Vogel WV; Marres HA; Merkx MA; Postema EJ; Oyen WJ; van den Hoogen FJ
    Laryngoscope; 2006 May; 116(5):809-13. PubMed ID: 16652093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Staging of head and neck squamous cell cancer with extended-field FDG-PET.
    Schwartz DL; Rajendran J; Yueh B; Coltrera M; Anzai Y; Krohn K; Eary J
    Arch Otolaryngol Head Neck Surg; 2003 Nov; 129(11):1173-8. PubMed ID: 14623746
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of positron emission tomography on the initial staging and therapy in locoregional advanced squamous cell carcinoma of the head and neck.
    Schmid DT; Stoeckli SJ; Bandhauer F; Huguenin P; Schmid S; von Schulthess GK; Goerres GW
    Laryngoscope; 2003 May; 113(5):888-91. PubMed ID: 12792328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loco-regional recurrence after surgical treatment of oral squamous cell carcinoma: Proposals for follow-up imaging based on literature, national guidelines and institutional experience.
    Loeffelbein DJ; Eiber M; Mayr P; Souvatzoglou M; Mücke T; von Bomhard A; Kesting MR; Wolff KD
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1546-52. PubMed ID: 26189143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective evaluation of outcome after transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma.
    Jerjes W; Upile T; Hamdoon Z; Mosse CA; Akram S; Hopper C
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Aug; 112(2):180-7. PubMed ID: 21232996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of quantitative 18 F-fluorodeoxyglucose uptake measurement to identify occult tonsillar carcinoma in patients with cervical metastasis of unknown primary tumours: a retrospective case-control study.
    Lee HJ; Kim JS; Roh JL; Lee JH; Cho KJ; Park GC; Choi SH; Nam SY; Kim SY
    Clin Otolaryngol; 2013 Feb; 38(1):30-8. PubMed ID: 23167514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [(18F)-2-fluorodeoxyglucose PET. Prospects for secondary prevention of mouth cavity carcinoma].
    Kunkel M; Kuffner HD; Reichert TE; Benz P; Förster GJ; Wagner W
    Mund Kiefer Gesichtschir; 2000 Mar; 4(2):105-10. PubMed ID: 10851884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A retrospective analysis of preoperative staging modalities for oral squamous cell carcinoma.
    Kähling C; Langguth T; Roller F; Kroll T; Krombach G; Knitschke M; Streckbein P; Howaldt HP; Wilbrand JF
    J Craniomaxillofac Surg; 2016 Dec; 44(12):1952-1956. PubMed ID: 27765552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck.
    Jacob R; Welkoborsky HJ; Mann WJ; Jauch M; Amedee R
    ORL J Otorhinolaryngol Relat Spec; 2001; 63(5):307-13. PubMed ID: 11528276
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.